Concert Nabs $200M Deal From Avanir to Make Psych Drugs

Lexington, MA based Concert Pharmaceuticals is working to optimize the pharmacokinetic properties of known drugs through a clever chemical modification. They recently announced a new partnership with Avanir, maker of the FDA approved drug Nuedexta for pseudobulbar atrophy, a common condition experienced by ALS patients.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail